Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12847221rdf:typepubmed:Citationlld:pubmed
pubmed-article:12847221lifeskim:mentionsumls-concept:C0022568lld:lifeskim
pubmed-article:12847221lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:12847221lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:12847221lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:12847221lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:12847221pubmed:issue2lld:pubmed
pubmed-article:12847221pubmed:dateCreated2003-7-8lld:pubmed
pubmed-article:12847221pubmed:abstractTextHerpetic stromal keratitis (HSK) is a chronic inflammatory process in corneal stroma that results from recurrent HSV type 1 infection. We used the murine model of HSK to demonstrate the importance of the interaction between an inducible T cell costimulatory receptor, 4-1BB, and its ligand, 4-1BB ligand (4-1BBL), in the development of this disease. In BALB/c mice, HSK ordinarily induced by infection with the RE strain of herpes was prevented by blocking 4-1BB/4-1BBL interaction, either by deleting 4-1BB (in mutant 4-1BB(-/-) mice) or by introducing mAbs against 4-1BBL. The majority of T cells infiltrating the infected corneas were 4-1BB(+) activated effector cells that expressed cell surface markers CD44, CD25, and/or CD62L, as well as chemokine receptors CCR1, CCR2, and CCR5, and a limited number of TCR Vbeta chains (Vbeta8.1/8.2, Vbeta8.3, Vbeta10b, and Vbeta5.1/5.2, in order of abundance). Analysis of cell surface phenotypes showed that the failure to develop HSK in the 4-1BB(-/-) mice was associated with a reduced expression of CD62L at the time of T cell migration into the corneal stroma.lld:pubmed
pubmed-article:12847221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:languageenglld:pubmed
pubmed-article:12847221pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12847221pubmed:statusMEDLINElld:pubmed
pubmed-article:12847221pubmed:monthJullld:pubmed
pubmed-article:12847221pubmed:issn0022-1767lld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:ReakC JCJlld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:ChoiJae HJHlld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:KwonByoung...lld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:KimYoung HYHlld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:KwonByungsukBlld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:KimWon YWYlld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:ParkHye YHYlld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:JungHyo WHWlld:pubmed
pubmed-article:12847221pubmed:authorpubmed-author:LeeHyeon WHWlld:pubmed
pubmed-article:12847221pubmed:issnTypePrintlld:pubmed
pubmed-article:12847221pubmed:day15lld:pubmed
pubmed-article:12847221pubmed:volume171lld:pubmed
pubmed-article:12847221pubmed:ownerNLMlld:pubmed
pubmed-article:12847221pubmed:authorsCompleteYlld:pubmed
pubmed-article:12847221pubmed:pagination576-83lld:pubmed
pubmed-article:12847221pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:meshHeadingpubmed-meshheading:12847221...lld:pubmed
pubmed-article:12847221pubmed:year2003lld:pubmed
pubmed-article:12847221pubmed:articleTitleBlocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis.lld:pubmed
pubmed-article:12847221pubmed:affiliationImmunomodulation Research Center, University of Ulsan, Ulsan, Korea.lld:pubmed
pubmed-article:12847221pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12847221pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12847221pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:21942entrezgene:pubmedpubmed-article:12847221lld:entrezgene
entrez-gene:21950entrezgene:pubmedpubmed-article:12847221lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12847221lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12847221lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12847221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12847221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12847221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12847221lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12847221lld:pubmed